We need to understand the impact of Covid-19 on wider health issues to shape better public health responses and limit long-term consequences. Drug resistance is one of these, Gemma Buckland-Merrett explains.
The industry-led AMR Action Fund is a major step forward in tackling the spread of drug-resistant infections. Jeremy Knox explains why governments too need to do more to stimulate antibiotic development.
Developing new antibiotics is one way of tackling the growing threat of drug-resistant infections. Tim Jinks explains why it's critical to step up investment in antibiotic development.
Discovering and then bringing new antibiotics to market is a tricky challenge – but one we need to solve if we want to be better protected against the growing threat of drug-resistant infections. Here’s why, and what has to happen to develop new medicines.
If you’re an advocate, policy maker or expert working on drug-resistant infections, you often need to write convincingly to make your audience understand and care about the issue. Here are some practical examples to help you do that.
The impact of drug-resistant infections is much higher than previously thought, as shown in a new report from the Centers for Disease Control.
Tackling big health challenges is dependent on science and innovation, but also on the public understanding and engaging with them.
We've used global research to develop effective ways to communicate about drug-resistant infections to inspire change.